SMTL ID : 2c5n.2 (1 other biounit)

Differential Binding Of Inhibitors To Active And Inactive Cdk2 Provides Insights For Drug Design

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.10 Å

Oligo State

hetero-1-1-mer

Ligands

1 x CK8: N-[4-(2,4-DIMETHYL-THIAZOL-5-YL)-PYRIMIDIN-2-YL]-N',N'-DIMETHYL-BENZENE-1,4-DIAMINE(Non-covalent)

CK8.1: 11 residues within 4Å: Chain A: I.10, V.18, A.31, K.33, E.81, F.82, L.83, H.84, Q.85, K.89, L.134 7 PLIP interactions: 7 interactions with chain A Hydrophobic interactions: A:I.10, A:A.31, A:K.33, A:Q.85, A:L.134 Hydrogen bonds: A:L.83, A:L.83

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kontopidis, G. et al., Differential Binding of Inhibitors to Active and Inactive Cdk2 Provides Insights for Drug Design. Chem.Biol. (2006)

Release Date

2006-03-01

Peptides

CELL DIVISION PROTEIN KINASE 2: A
CYCLIN A2: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

CELL DIVISION PROTEIN KINASE 2

CYCLIN A2

Related Entries With Identical Sequence